A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia
Clinical trial NCT01568333 · COMPLETED
Trial details
- NCT number
- NCT01568333
- Sponsor
- Shandong University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-10-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.